Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP571075.RAEBawWjYLOW6Ud4xgvTPr3kwcrbAVjxWBGjlbFsb5ck8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP571075.RAEBawWjYLOW6Ud4xgvTPr3kwcrbAVjxWBGjlbFsb5ck8130_assertion type Assertion NP571075.RAEBawWjYLOW6Ud4xgvTPr3kwcrbAVjxWBGjlbFsb5ck8130_head.
- NP571075.RAEBawWjYLOW6Ud4xgvTPr3kwcrbAVjxWBGjlbFsb5ck8130_assertion description "[Immediate early lowering of intracellular pH with lonidamine or lactate at extracellular pH 6.5 correlated positively with diminished cell viability within 48 h. These findings indicate that MCT1 is a potential therapeutic target and that neuroblastoma therapy may be enhanced by therapeutic strategies to inhibit or overwhelm MCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP571075.RAEBawWjYLOW6Ud4xgvTPr3kwcrbAVjxWBGjlbFsb5ck8130_provenance.
- NP571075.RAEBawWjYLOW6Ud4xgvTPr3kwcrbAVjxWBGjlbFsb5ck8130_assertion evidence source_evidence_literature NP571075.RAEBawWjYLOW6Ud4xgvTPr3kwcrbAVjxWBGjlbFsb5ck8130_provenance.
- NP571075.RAEBawWjYLOW6Ud4xgvTPr3kwcrbAVjxWBGjlbFsb5ck8130_assertion SIO_000772 17000864 NP571075.RAEBawWjYLOW6Ud4xgvTPr3kwcrbAVjxWBGjlbFsb5ck8130_provenance.
- NP571075.RAEBawWjYLOW6Ud4xgvTPr3kwcrbAVjxWBGjlbFsb5ck8130_assertion wasDerivedFrom befree-2016 NP571075.RAEBawWjYLOW6Ud4xgvTPr3kwcrbAVjxWBGjlbFsb5ck8130_provenance.
- NP571075.RAEBawWjYLOW6Ud4xgvTPr3kwcrbAVjxWBGjlbFsb5ck8130_assertion wasGeneratedBy ECO_0000203 NP571075.RAEBawWjYLOW6Ud4xgvTPr3kwcrbAVjxWBGjlbFsb5ck8130_provenance.